- Article metrics
- Last updated: Sat, 18 May 2024 10:17:41 Z
Long-term safety of brazikumab in the open-label period of a randomized phase 2a study of patients with Crohn’s disease
Access & Citations
-
- 926
- Article Accesses
-
- 0
- Web of Science
-
- 0
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.